Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis
暂无分享,去创建一个
Diederick E Grobbee | Arno W Hoes | A. Hoes | D. Grobbee | M. Cowie | T. McDonagh | S. Hardman | J. Kelder | Theresa A McDonagh | Martin R Cowie | Johannes C Kelder | Suzanna M C Hardman | Bernard Cost | B. Cost | Bernard Cost
[1] J. Goetze,et al. Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals , 2009, Heart.
[2] U. Dohrmann,et al. Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human Myocardium: Influence of Angiotensin II and Diastolic Fiber Length , 2000, Circulation.
[3] P. Leffers,et al. The influence of referral patterns on the characteristics of diagnostic tests. , 1992, Journal of clinical epidemiology.
[4] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[5] D E Grobbee,et al. External validation is necessary in prediction research: a clinical example. , 2003, Journal of clinical epidemiology.
[6] J. C. van Houwelingen,et al. A goodness-of-fit test for binary regression models, based on smoothing methods , 1991 .
[7] P Barton,et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. , 2009, Health technology assessment.
[8] M. Packer. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? , 2003, Circulation.
[9] Nancy R. Cook,et al. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[10] Diederick E Grobbee,et al. Test research versus diagnostic research. , 2004, Clinical chemistry.
[11] Eva Pietrzak,et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. , 2004, Archives of internal medicine.
[12] C. Frampton,et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. , 2003, Journal of the American College of Cardiology.
[13] C. Fonseca,et al. The diagnosis of heart failure in primary care: value of symptoms and signs , 2004, European journal of heart failure.
[14] H. Tunstall-Pedoe,et al. Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.
[15] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[16] Michael Böhm,et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.
[17] Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. , 1995, European heart journal.
[18] P. Poole‐Wilson,et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.
[19] M. Drazner,et al. B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.
[20] R. McKelvie,et al. Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. , 2008, Clinical biochemistry.
[21] M. Cowie,et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study , 2005, European journal of heart failure.
[22] P. Poole‐Wilson,et al. Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.
[23] S Greenland,et al. A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.
[24] Gary H Lyman,et al. The strengths and limitations of meta-analyses based on aggregate data , 2005, BMC Medical Research Methodology.
[25] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[26] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[27] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[28] R Mann,et al. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. , 2009, Health technology assessment.
[29] C. Fonseca. Diagnosis of heart failure in primary care , 2006, Heart Failure Reviews.
[30] A Rogier T Donders,et al. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. , 2004, Journal of clinical epidemiology.
[31] J. Juliard. [Heart failure in the elderly]. , 2009, La Revue du praticien.
[32] M. Landray,et al. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study , 2000, BMJ : British Medical Journal.
[33] M. Cowie,et al. Diagnosis of heart failure in primary care , 2010, Heart.
[34] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[35] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[36] S C Weller,et al. Assessing Rater Performance without a "Gold Standard" Using Consensus Theory , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[37] P. Hildebrandt,et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population , 2003, Heart.